Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NUTX
NUTX logo

NUTX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
152.500
Open
151.790
VWAP
150.13
Vol
144.43K
Mkt Cap
1.04B
Low
147.375
Amount
21.68M
EV/EBITDA(TTM)
4.17
Total Shares
6.88M
EV
1.24B
EV/OCF(TTM)
4.55
P/S(TTM)
1.17
Nutex Health Inc. is a healthcare management and operations company. The Company operates in three segments: the Hospital division, the Population Health Management (PHM) division, and the Real Estate division. The Hospital division owns, develops and operates healthcare models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates over 27 facilities in 12 states. In addition, it has financial and operating relationships with multiple professional entities and real estate entities. The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). Through its Management Services Organization, it provides management, administrative and other support services to its affiliated hospitals and physician groups. The Real Estate division comprises the Real Estate Entities, which owns the land and hospital buildings which are leased to its hospital entities.
Show More

Events Timeline

(ET)
2026-04-30
17:20:00
Nutex Health Reports Q1 Revenue of $216.49M
select
2026-03-06 (ET)
2026-03-06
09:00:00
Oil Prices Surge as Markets Decline Due to Geopolitical Risks
select
2026-03-06
08:10:00
Nutex Health Reports $11.8M Net Income for Q4 2025
select
2026-03-05 (ET)
2026-03-05
19:30:00
Marvell Technology Shares Rise 15% After Earnings
select
2026-03-05
18:50:00
Nutex Health Authorizes $25M Stock Repurchase Program
select
2026-03-05
18:50:00
Nutex Health Q4 Revenue $151.7M, Below Expectations
select
2026-03-05
18:50:00
Nutex Health Reports 2025 EPS of $10.48 vs. $9.69 in 2024
select
2025-12-04 (ET)
2025-12-04
05:40:00
Nutex Health Extends Stock Repurchase Program to March 2026
select
2025-11-26 (ET)
2025-11-26
16:12:33
Nutex Health claims 'Capybara Research appears to be a non-existent entity'
select

News

Globenewswire
7.0
06-09Globenewswire
Nutex Health Executives Accused of Breaching Fiduciary Duties
  • Investigation Launched: Kuehn Law, PLLC is investigating whether Nutex Health, Inc. executives breached their fiduciary duties to shareholders, with allegations that could expose the company to significant legal risks.
  • False Statements Revealed: A federal securities lawsuit claims that Nutex Health failed to disclose fraudulent activities associated with its partnership with HaloMD, raising doubts about the sustainability of the company's revenues and potentially impacting the accuracy of future financial reports.
  • Internal Control Deficiencies: The company is accused of overstating its ability to remediate material weaknesses in its internal controls over financial reporting, leading to difficulties in accounting for stock-based compensation obligations and increasing the risk of delays in filing financial reports.
  • Shareholder Rights at Risk: Due to these issues, Nutex Health's business prospects were overstated, resulting in materially false and misleading public statements at all relevant times, prompting shareholders to contact legal counsel promptly to protect their rights.
NASDAQ.COM
2.0
05-04NASDAQ.COM
Nutex Health NUTX Q1 2025 Earnings Transcript
NASDAQ.COM
2.0
05-04NASDAQ.COM
Nutex Health NUTX Q2 2025 Earnings Transcript
seekingalpha
9.5
05-01seekingalpha
Nutex Health Reports Q1 2026 Earnings Highlights
  • Revenue Growth: Nutex Health reported total revenue of $216.5 million in Q1 2026, reflecting a 2.2% increase, with hospital division revenue at $207.6 million, indicating stable growth in the healthcare service sector.
  • Net Income Increase: Net income rose to $46.8 million, showcasing improvements in cost control and operational efficiency, although adjusted EBITDA fell by 21% to $57.6 million, primarily due to the timing of IDR expense recognition.
  • Share Repurchase Program: The company completed its inaugural $25 million share repurchase program and initiated a second program of the same size during the quarter, demonstrating management's confidence in future growth and commitment to capital returns.
  • Hospital Development Strategy: The Board approved Nutex to directly invest in the development and construction of new hospital facilities, with each project estimated to cost between $20 million and $30 million, aiming to open three new hospitals in the second half of 2026 to enhance market competitiveness.
NASDAQ.COM
9.5
05-01NASDAQ.COM
Nutex Health Reports Significant Earnings Growth in Q1
  • Significant Earnings Growth: Nutex Health reported Q1 earnings of $46.81 million, translating to $6.52 per share, a substantial increase from last year's $21.22 million and $3.33 per share, indicating a marked improvement in the company's profitability.
  • Slight Revenue Increase: The company's revenue for the first quarter reached $216.49 million, up 2.2% from $211.79 million last year, reflecting a stable performance in the market despite the modest growth rate.
  • Increased Market Confidence: The dual growth in earnings and revenue not only boosts investor confidence but may also attract more attention from potential investors, laying the groundwork for future capital operations and expansion.
  • Strategic Development Potential: With enhanced profitability, Nutex Health is positioned to increase investments in new projects and market expansions, further solidifying its market position in the healthcare industry.
seekingalpha
9.5
04-30seekingalpha
Nutex Health Q1 Earnings Beat Expectations with Strong EPS
  • Earnings Beat: Nutex Health reported a Q1 GAAP EPS of $6.52, exceeding expectations by $1.59, indicating strong profitability that may attract more investor interest.
  • Revenue Miss: Despite a 2.2% year-over-year revenue increase to $216.49 million, the figure fell short of expectations by $11.31 million, reflecting competitive pressures that could impact future growth strategies.
  • Positive Stock Reaction: Shares rose 3.2% in after-hours trading, suggesting a favorable investor response to the earnings report, which may enhance market confidence in the company's future performance.
  • Stock Buyback Program: The company authorized a stock repurchase program of up to $25 million, aimed at enhancing shareholder value and stabilizing the stock price, demonstrating management's confidence in the company's future prospects.
Wall Street analysts forecast NUTX stock price to rise
2 Analyst Rating
Wall Street analysts forecast NUTX stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
230.00
Averages
265.00
High
300.00
Current: 0.000
sliders
Low
230.00
Averages
265.00
High
300.00
Lake Street
Ben Haynor
Buy
initiated
$235
AI Analysis
2026-06-02
Reason
Lake Street
Ben Haynor
Price Target
$235
AI Analysis
2026-06-02
initiated
Buy
Reason
Lake Street analyst Ben Haynor initiated coverage of Nutex Health with a Buy rating and $235 price target. Shares of micro-hospital operator trade at a \"mere ~3x EV/EBITDA,\" notes the analyst, who sees this as due to several factors. These include a reverse-merger path to public markets, a subsequent lack of sell-side coverage, a 2025 short report \"filled with innuendo and an unbalanced look at the IDR process,\" and the fact that the No Surprises Ac is \"a recent development that is poorly understood by the investment community,\" the analyst tells investors.
Maxim
Maxim
Buy
downgrade
$225 -> $205
2025-08-26
Reason
Maxim
Maxim
Price Target
$225 -> $205
2025-08-26
downgrade
Buy
Reason
Maxim lowered the firm's price target on Nutex Health to $205 from $225 and keeps a Buy rating on the shares. On August 14th, the company filed an NT 10-Q notification of inability to timely file its 10-Q for the three months ended 6/30/25, due to the incorrect accounting classification of certain non-cash obligations, the analyst tells investors in a research note. The firm views the accounting restatements, arbitration dynamics, and lawsuits against Nutex's primary arbitration vendor, HaloMD, as potential headwinds to the stock price, Maxim added.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NUTX
Unlock Now

Valuation Metrics

The current forward P/E ratio for Nutex Health Inc (NUTX.O) is 0.00, compared to its 5-year average forward P/E of -23.41. For a more detailed relative valuation and DCF analysis to assess Nutex Health Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-23.41
Current PE
0.00
Overvalued PE
72.87
Undervalued PE
-119.68

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
53.86
Current EV/EBITDA
3.05
Overvalued EV/EBITDA
158.01
Undervalued EV/EBITDA
-50.29

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
2.82
Current PS
1.07
Overvalued PS
9.64
Undervalued PS
-3.99

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what's the best stock to buy Winner?
Intellectia · 73 candidates
Price: >= $-100.00Volume: >= -100Relative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20, PriceAboveMA200Month Price Change Pct: >= $0.00Quarter Price Change Pct: >= $0.00Ema 20: >= -100Ema 200: >= -100Monthly Average Dollar Volume: >= -100Macd: bullish
Ticker
Name
Market Cap$
top bottom
BAND logo
BAND
Bandwidth Inc
1.44B
CTW logo
CTW
CTW Cayman
179.09M
INSG logo
INSG
Inseego Corp
329.52M
NRXS logo
NRXS
Neuraxis Inc
92.96M
NAVN logo
NAVN
Navan Inc
4.63B
STX logo
STX
Seagate Technology Holdings PLC
163.00B
what are some good small cap stocks to buy
Intellectia · 27 candidates
Market Cap: 300.00M - 2.00BBeta: ModerateRiskWeekly Average Turnover: >= 1,000,000Pe Ttm: <= 16Annual Revenue Yoy Growth: >= 25.0%
Ticker
Name
Market Cap$
top bottom
CMRE logo
CMRE
Costamare Inc
1.91B
AGIO logo
AGIO
Agios Pharmaceuticals Inc
1.58B
AESI logo
AESI
Atlas Energy Solutions Inc
1.44B
TWO logo
TWO
Two Harbors Investment Corp
1.40B
QURE logo
QURE
Uniqure NV
1.35B
IMTX logo
IMTX
Immatics NV
1.34B

Whales Holding NUTX

D
Divisadero Street Capital Management, LP
Holding
NUTX
+21.70%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Nutex Health Inc (NUTX) stock price today?

The current price of NUTX is 150.51 USD — it has increased 2.82

What is Nutex Health Inc (NUTX)'s business?

Nutex Health Inc. is a healthcare management and operations company. The Company operates in three segments: the Hospital division, the Population Health Management (PHM) division, and the Real Estate division. The Hospital division owns, develops and operates healthcare models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates over 27 facilities in 12 states. In addition, it has financial and operating relationships with multiple professional entities and real estate entities. The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). Through its Management Services Organization, it provides management, administrative and other support services to its affiliated hospitals and physician groups. The Real Estate division comprises the Real Estate Entities, which owns the land and hospital buildings which are leased to its hospital entities.

What is the price predicton of NUTX Stock?

Wall Street analysts forecast NUTX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NUTX is265.00 USD with a low forecast of 230.00 USD and a high forecast of 300.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Nutex Health Inc (NUTX)'s revenue for the last quarter?

Nutex Health Inc revenue for the last quarter amounts to 216.49M USD, increased 2.22

What is Nutex Health Inc (NUTX)'s earnings per share (EPS) for the last quarter?

Nutex Health Inc. EPS for the last quarter amounts to 6.52 USD, increased 95.80

How many employees does Nutex Health Inc (NUTX). have?

Nutex Health Inc (NUTX) has 944 emplpoyees as of June 21 2026.

What is Nutex Health Inc (NUTX) market cap?

Today NUTX has the market capitalization of 1.04B USD.